Top Markets
Coin of the day
Pasithea Therapeutics Corp. Pasithea Therapeutics Corp.

Pasithea Therapeutics Corp.

KTTA
Rangering i aksjer #35798
Pasithea Therapeutics Corp. functions as a biotechnology firm dedicated to the... Pasithea Therapeutics Corp. functions as a biotechnology firm dedicated to the discovery and advancement of novel therapeutic solutions for various psychiatric and neurological conditions. Beyond its research endeavors, the company also plans to establish and manage clinics specializing in depression treatment. These facilities are designed to offer business support, employing trained pharmacists to administer intravenous ketamine infusions. Founded in 2020, the corporation's primary operations are based in Miami Beach, Florida.
Aksjekurs
$0.46
Sist synkronisert: 2026-07-31
Markedsverdi
$3.42M
Endring (1 dag)
3.60%
Endring (1 år)
-34.54%
Land
US
Handel Pasithea Therapeutics Corp. (KTTA)

Kategori

Pris KTTA pris med markedsverdi på B
Pasithea Therapeutics Corp. Pasithea Therapeutics Corp.
KTTA
$0.46
Markedsverdi av Pasithea Therapeutics Corp.(KTTA)
Markedsverdi: $3.42M
Per August 2026 har Pasithea Therapeutics Corp. en markedsverdi på $3.42M. Dette gjør Pasithea Therapeutics Corp. til det 35798th mest verdifulle selskapet i verden basert på markedsverdi ifølge våre data. Markedsverdi er den totale markedsverdien av et børsnotert selskaps utestående aksjer og brukes vanligvis til å måle hvor mye et selskap er verdt.
Markedsverdihistorikk for Pasithea Therapeutics Corp. fra 2021 til 2026
KTTA sammenlignet med topp 5 mest populære stocks
Pris på KTTA Eiendel B Markedsverdi for B Resultater
Pasithea Therapeutics Corp. Pasithea Therapeutics Corp.
$732,538 $3.42M
$5.452T +159,247,394.66%
Pasithea Therapeutics Corp. Pasithea Therapeutics Corp.
$603,300 $3.42M
$4.490T +131,152,102.86%
Pasithea Therapeutics Corp. Pasithea Therapeutics Corp.
$559,280 $3.42M
$4.162T +121,582,616.58%
Pasithea Therapeutics Corp. Pasithea Therapeutics Corp.
$493,971 $3.42M
$3.676T +107,384,809.47%
Pasithea Therapeutics Corp. Pasithea Therapeutics Corp.
$380,661 $3.42M
$2.833T +82,752,263.50%